Artigo Revisado por pares

Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia

2018; Springer Nature; Volume: 33; Issue: 1 Linguagem: Inglês

10.1038/s41375-018-0167-0

ISSN

1476-5551

Autores

Samir H. Barghout, Parasvi S. Patel, Xiaoming Wang, Guozhou Xu, Simon Kavanagh, Ondrej Halgas, Sara Farshchi Zarabi, Marcela Gronda, Rose Hurren, Danny V. Jeyaraju, Neil MacLean, Shawn Brennan, Marc L. Hyer, Allison Berger, Tary Traore, Michael A. Milhollen, Adam C. Smith, Mark D. Minden, E.F. Pai, Razqallah Hakem, Aaron D. Schimmer,

Tópico(s)

Protein Degradation and Inhibitors

Referência(s)
Altmetric
PlumX